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Reactive oxygen species play a key role in pathophysiology
of cardiovascular diseases by modulating G-protein-coupled
receptor signaling. We have shown that treatment of animal
models of diabetes and aging with tempol decreases
oxidative stress and restores renal dopamine D1 receptor
(D1R) function. In present study, we determined whether
oxidation of D1R and upregulation of mitogen-activated
protein kinases (MAPK) were responsible for decreased D1R
signaling in obese animals. Male lean and obese Zucker rats
were supplemented with antioxidants tempol or lipoic acid
for 2 weeks. Compared to lean, obese animals were
hyperglycemic and hyperinsulinemic with increased
oxidative stress, D1R oxidation and decreased glutathione
levels. These animals had decreased renal D1R affinity and
basal coupling to G-proteins. SKF-38393, a D1R agonist failed
to stimulate G-proteins and adenylyl cyclase. Obese animals
showed marked increase in renal MAPK activities. Treatment
of obese rats with tempol or lipoic acid decreased blood
glucose, reduced oxidative stress, and restored the basal D1R
G-protein coupling. Antioxidants also normalized MAPK
activities and restored D1R affinity and SKF-38393 induced
D1R G-protein coupling and adenylyl cyclase stimulation.
These studies show that D1R oxidation and MAPK
upregulation contribute to D1R dysfunction in obese animals.
Consequently, antioxidants while reducing the oxidative
stress normalize the MAPK activities and restore D1R
signaling.
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Renal dopamine system is recognized as an important
modulator of sodium balance and blood pressure.1 During
increased sodium intake, dopamine causes more than 50% of
sodium excretion and participates in maintaining sodium
homeostasis.2 Dopamine exerts its natriuretic and diuretic
actions via activation of D1 receptors in the renal proximal
tubules.3,4 In proximal tubules, D1 receptors inhibit activities
of Na/H exchanger 3 (NHE3) and Na/phosphate (Pi) co-
transporter in luminal membrane and Na/HCO co-trans-
porter and Na/K ATPase (NKA) in basolateral membrane
(BLM).1,4–6 This action of dopamine on NHE3 and Na/HCO
co-transporter activities is due to activation of cyclic
adenosine mono phosphate (cAMP)/protein kinase A path-
way.1,6–8 Dopamine can inhibit NKA activity by activating G-
protein-linked pathway independent of protein kinase A
while involving protein kinase C (PKC) and phosphatidyli-
nositol 3 kinase.7,9,10
Abnormalities in renal dopamine receptor function are
described in human genetic hypertension and abnormal renal
D1 receptor function contributes to the development of
genetic hypertension and hypertension associated with
obesity and diabetes in animals.1,10–13 The failure of renal
dopamine system is not caused by decreased renal dopamine
production but by a defective D1 receptor G-protein
coupling.1,10 Although the reduced receptor expression and/
or increased receptor phosphorylation have been shown to
cause receptor G-protein uncoupling, the exact mechanism is
still elusive.10–13
Previously, we have shown that in obese Zucker rats, an
animal model of obesity and type II diabetes, the defect in
renal dopamine D1 receptor was associated with increased
oxidative stress.13 Treatment of these animals with tempol, a
superoxide dismutase (SOD) mimetic compound or with
insulin sensitizer rosiglitazone decreased oxidative stress
and restored D1 receptor G-protein coupling and
function.11,13 Similar observations were made in streptozo-
tocin treated Sprague–Dawley rats and old Fisher 344
rats where antioxidant tempol decreased oxidative
stress and restored D1 receptor function, thus indicating
that oxidative stress contributes to decreased D1 receptor
functioning.14,15 However, the precise mechanisms
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responsible for oxidative stress-associated D1 receptor defect
remained to be elucidated.
Reactive oxygen species serve as second messengers in
various signal transduction pathways.16–19 Among many
intracellular signaling molecules, reactive oxygen species-
induced cellular events have been implicated in part to
activation of mitogen-activated protein kinases (MAPK),
including the extracellular signal regulated kinase (ERK)
1/ERK2, c-jun NH2-terminal kinase (JNK), and p38
MAPK.16–19 Studies have shown that MAPK are activated in
cardiovascular diseases such as diabetes and hyperten-
sion.16–19 Furthermore, it is shown that MAPK can modulate
dopamine receptor function in various organs including
kidneys.20 The present study was conducted to elucidate the
role of MAPK in renal proximal tubular D1 receptor
dysfunction of obese Zucker rats.
RESULTS
As shown in Table 1, body weight and blood glucose were
significantly higher in obese rats compared to lean rats.
Treatment with tempol or lipoic acid showed no effect on the
body weight of obese animals but markedly reduced their
blood glucose. As shown in Table 2, tempol or lipoic acid
showed no effect on body weight and blood glucose of lean
rats. Tempol and lipoic acid did not change the water or food
intake in lean or obese animals (data not shown).
Antioxidants reduced oxidative stress in obese animals
Compared to lean rats, obese animals had significantly higher
plasma and urinary 8-isoprostane levels (Table 1). Renal
proximal tubules from obese rats showed significant decrease
in reduced glutathione along with increased levels of oxidized
glutathione compared to lean rats (Table 1). In addition, the
renal nitrotyrosine (Figure 1) and carboxymethyl lysine
(Table 1) levels were significantly higher in obese compared
to lean rats.
As illustrated in Figure 1b, renal D1 receptors from obese
rats have increased carbonyl content compared to lean
rats. The Western blotting analysis of various subunits of
renal nicotinamide adenine dinucleotide phosphate
(NAD(P)H) oxidase in obese animals did not show any
upregulation of this enzyme compared to lean rats (Figure
2a–d). In addition, the low-temperature sodium dodecyl
sulfate-polyacrylamide gel electrophoresis immunoblotting
of endothelial nitric oxide synthase (NOS) showed
similar monomer vs dimer expression in lean and obese
rats (data not shown). Furthermore, incubation of
homogenates with dihydroethidium and NAD(P)H oxidase
or NOS substrates caused similar O2
 production (fluores-
cence units/min/mg protein) in lean and obese animals,
NAD(P)H oxidase – lean: 891.07121.0, obese:
1049.07117.0; NOS – lean: 651.0785, obese: 819.07113.0.
Taken together, these data suggest that NAD(P)H oxidase and
NOS are not the predominant source of superoxide
production in obese animals. Treatment of obese animals
with tempol or lipoic acid significantly decreased the plasma
and urinary 8-isoprostane levels, renal nitrotyrosine and
carboxymethyllysine levels, and D1 receptor carbonyl content
and also restored the renal glutathione levels in obese animals
(Table 1 and Figure 1 a and b). In lean rats, antioxidant
Table 1 | Effect of tempol and lipoic acid on body weight, glucose, and oxidative markers in lean and obese Zucker rats
Lean Obese Obese-tempol Obese-lipoic acid
Body weight, g 280.5712.0 490.0716.2a 540.5730.2a 533720.9a
Blood glucose, mg/dl 109.176.2 209.078.2a 149.074.3a,b 139.373.8a,b
8-isoprostane, urine (pg/mg creatinine) 593.0729.2 992.0732.1a 625.0726.3b 670.0731.6b
8-isoprostane, plasma (pg/mg creatinine) 32.172.2 49.172.4a 36.172.0b 37.972.0b
CML (optical density/mg protein) 0.3870.06 1.470.1a 0.5470.08b 0.5970.1b
GSH nmol/mg protein 0.8970.05 0.4470.03a 1.070.1b 0.9970.09b
GSSG pmol/mg protein 28.071.1 50.073.1a 32.072.9b 34.072.3b
CML, carboxymethyl lysine; GSH, reduced glutathione; GSSG, oxidized glutathione.
Data (mean7s.e.m. of 6–8 different animals) were analyzed by ANOVA and post hoc Newman–Keuls multiple comparison test.
Po0.05 was considered statistically significant.
aSignificantly different from lean rats.
bObese-tempol and obese-lipoic acid significantly different from obese rats.
Table 2 | Effect of tempol and lipoic acid on body weight, glucose, and oxidative markers in lean Zucker rats
Lean Lean-tempol Lean-lipoic acid
Body weight, g 280.5712.0 310.5710.0 308.5711.2
Blood glucose, mg/dl 109.176.2 104.176.9 100.175.3
8-isoprostane, urine (pg/mg creatinine) 593.0729.2 543.0722.3 545.0734.3
8-isoprostane, plasma (pg/mg creatinine) 32.172.2 30.173.1 29.971.6
CML (optical density/mg protein) 0.3870.06 0.3570.05 0.3470.07
GSH nmol/mg protein 0.8970.05 0.9570.07 1.070.2
GSSG pmol/mg protein 28.071.1 22.071.9 23.071.3
CML, carboxymethyl lysine; GSH, reduced glutathione; GSSG, oxidized glutathione.
Data (mean7s.e.m. of 6–8 different animals) were analyzed by ANOVA and post hoc Newman–Keuls multiple comparison test.
Po0.05 was considered statistically significant.
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supplementation showed no effect on either oxidative or
antioxidative markers (Table 2).
Antioxidants restored renal D1 receptor agonist affinity in
obese animals
To determine the affinity of D1 receptors with agonist, we
used fenoldopam (FD) to displace [3H]SCH-23390 binding
in proximal tubular membranes from lean and obese rats.
The agonist affinity for both high- and low-affinity receptors
was reduced by a one-log unit of FD concentration in obese
compared with lean rats (Figure 3, inset). Treatment with
tempol or lipoic acid restored the affinity of renal D1
receptors in obese animals (Figure 3 and inset). Tempol or
lipoic acid had no effect on D1 receptor affinity in lean rats
(Table 3).
Antioxidants increased co-immunoprecipitation of renal D1
receptors with Gas in obese animals
In assessing specific coupling of D1 receptors to G-proteins,
we employed direct [3H]SCH-23390 binding in immunopre-
cipitates of Gas proteins obtained from solubilized mem-
branes of renal proximal tubules. The results shown in Figure
4a demonstrate that Gas antiserum immunoprecipitated
[3H]SCH-23390 binding sites in obese Zucker rats are
significantly reduced compared to lean. In obese animals
treated with tempol or lipoic acid, the co-immunoprecipi-
tated D1 binding sites with Gas antiserum were similar to
lean rats. Gai antiserum failed to co-immunoprecipitate
significant D1 binding sites. Immunoprecipitates of Gas
antisera were also blotted with a specific D1A and Gas
antibodies. The data presented in Figure 4b shows that the
D1A protein that co-immunoprecipitated with Gas was
significantly reduced in obese rats compared to lean rats and
treatment with tempol or lipoic acid restored the co-
immunoprecipitation of D1a with Gas proteins. Gas antisera
immunoprecipitated similar amount of Gas protein both in
lean, obese, and antioxidant-supplemented obese rats (Figure
4c). Tempol and lipoic acid showed no effect on basal D1
receptor G-protein coupling in lean rats (data not shown).
Antioxidants restored SKF-38393-induced [35S]GTPcS binding
to Gas proteins in obese animals
Incubation of membranes with SKF-38393 followed by
immunoprecipitation with Gas antiserum showed significant
increase in [35S]GTPgS membrane binding in lean rats
(Figure 5). However, SKF-38393 failed to increase
[35S]GTPgS membrane binding in obese rats. Treatment
with tempol or lipoic acid restored the SKF-38393-induced
[35S]GTPgS binding in obese rats. In contrast, co-immuno-
precipitation with Gai failed to show the SKF-38393-induced
increase in [35S]GTPgS. The activation of G-proteins was D1
receptor specific as the effect of D1 agonist SKF-38393 was
completely blocked by D1 antagonist SCH-23390. In lean rats
neither tempol or lipoic acid had any effect on SKF-38393-
induced GTPgS binding (data not shown).
Antioxidants restored SKF-38393-mediated cAMP production
in obese animals
Incubation of proximal tubular membranes with D1 selective
agonist SKF-38393 from lean rats resulted in significant
elevations in cAMP production. The results summarized in
Table 4 indicate that adenylyl cyclase activation in response to
SKF-38393 was minimal in membranes from obese rats.
Treatment with tempol or lipoic acid restored the SKF-
38393-dependent cAMP accumulation in obese rats. Direct
enzyme stimulation with forskolin was similar in lean and
obese rats (Table 4). Tempol and lipoic acid did not effect the
basal or forskolin-induced adenylyl cyclase stimulation
(Table 3).
We measured the basal expression and activities of NKA
and NHE3, the major sodium transporters of renal proximal
tubules in BLM and brush border (apical) membrane (BBM),
respectively. No difference was observed in protein abun-
dance (data not shown) or activities of these transporters
between lean and obese animals, NKA activity (ouabain-
sensitive inorganic phosphate release, nmol/mg protein/min)
– lean: 269.0722.0, obese: 248.0719.0; NHE3 activity
(amiloride-sensitive 22Naþ uptake, nmol/mg protein/min)
– lean: 2.370.2, obese: 2.670.3.
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Figure 1 | Effect of antioxidants on oxidative stress. Effect of
tempol (T) and lipoic acid (LA) supplementation on (a) nitrotyrosine
and (b) D1 receptor oxidation, in renal proximal tubules from lean (L),
obese (O), obese-tempol (OT), and obese-lipoic acid (OLA) rats. Upper
panel: representative Western blot. Bars represent density (arbitrary
units), mean7s.e.m. of 5–6 different experiments (animals). Data
were analyzed by ANOVA followed by Newman–Keuls multiple test;
Po0.05 was considered statistically significant. *Obese (O)
significantly different from other groups.
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Figure 2 | Effect of antioxidants on NAD(P)H protein expression. Effect of tempol (T) and lipoic acid (LA) supplementation on basal NAD(P)H
oxidase protein expression, (a) gp91phox, (b) p22phox, (c) Rac-1, and (d) p47phox in renal proximal tubules from lean (L), obese (O),
obese-tempol (OT), and obese-lipoic acid (OLA) rats. Upper panels: representative immunoblots. Bars represent density (arbitrary units),
mean7s.e.m. of 5–6 different experiments (animals). Data were analyzed by ANOVA followed by Newman–Keuls multiple test; Po0.05 was
considered statistically significant.
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Figure 3 | Effect of tempol (T) and lipoic acid (LA)
supplementation on FD displacement of [3H]SCH-23390 in renal
proximal tubular membranes from lean, obese, obese-tempol,
and obese-lipoic acid rats. Total binding was determined in the
absence of any drug, whereas nonspecific binding was determined in
the presence of unlabelled SCH-23390 (10 mM). Competition curve
was plotted with the percentage of radioligand bound values
obtained as means7s.e. from 4–5 different experiments (animals).
Data were analyzed by ANOVA followed by Newman–Keuls multiple
test; Po0.05 was considered statistically significant. *Obese
significantly different from other groups.
Table 3 | Effect of tempol and lipoic acid on basal D1 receptor
affinity, NKA, and NHE3 activity and SKF-38393-induced
adenylyl cyclase activation in renal proximal tubular
membranes from lean rats
Lean Lean-tempol Lean-lipoic acid
EC501 5.92 1011 4.58 1011 3.78 1011
EC502 4.72 107 3.85 107 4.22 107
NKA activity
Basal 288.6720.6 269.2722.1 255.1727.9
NHE3
Basal 2.370.2 2.570.2 2.170.3
Adenylyl cyclase activity
Basal 55.274.4 50.273.4 53.273.2
SKF-38393 (100 mM) 78.274.9a 80.074.9a 74.173.2a
Forskolin (10mM) 188.2712.3a 201.2711.3a 195.0716.4a
cAMP, cyclic adenosine mono phosphate; NHE3, Na/H exchanger 3; NKA, Na/K
ATPase.
Effective concentration (EC50) is expressed as [M], NKA and NHE3 are expressed as
nmol pi/mg protein/min and nmol 22Na+/mg protein/min, respectively. Adenylyl
cyclase activity was determined as cAMP accumulation (fmol/mg protein). Data
(mean7s.e.m. of 6–8 different animals) were analyzed by ANOVA and post hoc
Newman-Keuls multiple comparison test. Po0.05 was considered statistically
significant.
aSignificantly different from respective basal.
400 Kidney International (2007) 71, 397–406
o r i g i n a l a r t i c l e AA Banday et al.: Role of MAP kinase in D1 receptor dysfunction
Antioxidants normalized the basal activities of renal ERK1/2,
p38, and JNK in obese animals
As shown in Figure 6a–c, the activities of ERK1/2, p38, and
JNK were significantly higher in obese rats compared to lean
rats. To investigate the role of oxidative stress on MAPK
activation, we studied the effect of tempol and lipoic acid on
ERK1/2, p38, and JNK activation. As illustrated in Figure
6a–c, tempol and lipoic acid normalized the ERK1/2, p38,
and JNK activities to basal levels in obese animals.
Incubation of proximal tubules from lean and obese
animals with 25mM H2O2 for 30 min caused significant
increase in malondialdehyde levels; however, the increase was
more pronounced in lean proximal tubules compared to obese
(Figure 7a). Interestingly, incubation of proximal tubules from
lean rats with H2O2 caused significant increase in ERK1/2
(Figure 7b) and D1 receptor downregulation and uncoupling
from G-proteins (Figure 8a and b). Inhibition of H2O2-
induced ERK1/2 kinase activation with U-0126 (Figure 7b)
attenuated H2O2-mediated D1 receptor desensitization (Figure
8a and b). H2O2 failed to reduce D1 receptor expression and
coupling or upregulate ERK1/2 in proximal tubules from
obese animals (Figures 7 and 8). Also, U-0126 failed decrease
ERK1/2 activity or restore D1 receptor signaling in proximal
tubules of these animals (Figures 7 and 8).
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Figure 4 | Effect of tempol (T) and lipoic acid (LA) supplementation on basal D1 receptor G-protein coupling in renal proximal tubular
membranes from lean (L), obese (O), obese-tempol (OT), and obese-lipoic acid (OLA) rats. Membrane G-proteins were
immunoprecipitated with Gas or Gai antibodies and incubated with (a) D1 receptor ligand [3H]SCH-23390 or immunoblotted for (b) D1a and
(c) Gas protein. Upper panel (b and c): representative immunoblots. Bars represent (a) specific [3H]SCH-23390 binding, (b and c) density
arbitrary units, mean7s.e.m. of 5–6 different experiments (animals). Data were analyzed by ANOVA followed by Newman–Keuls multiple test;
Po0.05 was considered statistically significant.
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Figure 5 | Effect of tempol and lipoic acid supplementation on
SKF-38393-induced D1 receptor G-protein coupling in renal
proximal tubular membranes from lean, obese, obese-tempol,
and obese-lipoic acid rats. Membranes were incubated with
[35S]GTPgS in the presence or absence of SKF-38393 and G-proteins
were immunoprecipitated with Gas or Gai antibodies. Bars represent
specific binding, mean7s.e.m. of 5–6 different experiments (animals).
Data were analyzed by ANOVA followed by Newman–Keuls multiple
test; Po0.05 was considered statistically significant.
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DISCUSSION
These results show that defect in D1 receptor function in
obese Zucker rats is associated with increased D1 receptor
oxidation and upregulation of ERK1/2, JNK, and p38 MAPK
activities. Treatment with antioxidants tempol and lipoic acid
reduced oxidative stress and normalized ERK1/2, JNK, and
p38 MAPK activities. The present study demonstrates that in
obese animals the D1 receptors have reduced affinity and are
uncoupled from G-proteins in basal state. SKF-38393, a D1
receptor agonist failed to elicit [35S]GTPgS binding and
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Figure 6 | Effect of antioxidants on MAP kinase activity. Effect of tempol (T) and lipoic acid (LA) supplementation on (a) ERK1/2, (b) p38, and
(c) JNK activities in renal proximal tubules from lean (L), obese (O), obese-tempol (OT), and obese-lipoic acid (OLA) rats. (a and b) Top panel
represents ERK1/2 or p38 phosphorylated protein, middle panel represents ERK1/2 or p38 protein abundance, and lower panel (bars) represent
the ratio of top and middle panel (phosphorylated protein/protein abundance). (c) Upper panel: representative Western blots. Bars represent
density (arbitrary units), mean7s.e.m. of 5–6 different experiments (animals). Data were analyzed by ANOVA followed by Newman–Keuls
multiple test; Po0.05 was considered statistically significant. *Obese (O) significantly different from other groups.
Table 4 | Effect of tempol and lipoic acid on SKF-38393-induced adenylyl cyclase activation in renal proximal tubular
membranes from lean and obese animals
Lean Obese Lean-tempol Obese-lipoic acid
Basal 55.274.4 53.272.2 50.074.2 52.173.9
SKF-38393 (100mM) 78.274.9a 64.173.8 70.074.2a 73.173.6a
Forskolin (10mM) 188.2712.3a 209.0716.9a 216.6714.3a 206.2717.9a
Adenylyl cyclase activity was expressed as cAMP accumulation (fmol/mg protein). Data (mean7s.e.m. of 6–8 different animals) were analyzed by ANOVA and post hoc
Newman–Keuls multiple comparison test. Po0.05 was considered statistically significant.
aSignificantly different from respective basal.
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increase the accumulation of cAMP in renal proximal tubular
membranes of obese animals. Furthermore, tempol and
lipoic acid restored the D1 receptor affinity and normalized
the SKF-38393-induced D1 receptor G-protein coupling and
adenylyl cyclase activation. Finally, the direct exposure of
proximal tubules to H2O2, an oxidant caused upregulation of
ERK1/2 and reduced D1 receptor signaling in lean rats. The
pre-incubation of proximal tubules with MAPK kinase
inhibitor U-0126 inhibited ERK1/2 activation and blocked
the oxidative stress-mediated D1 receptor defect.
The novel finding of this study is that in obese animals
oxidative stress-mediated upregulation of MAPK is asso-
ciated with defective D1 receptor signaling. Various studies
have shown that diabetes is associated with increased
formation of free radicals and decrease in antioxidant
potential.21–25 In present studies, we also observed a
significant increase in protein and lipid oxidation, as
evidenced by increased nitrotyrosine and 8-isoprostane levels
in obese Zucker rats. A variety of different factors such as
hyperglycemia and dyslipidemia probably contribute to the
increased oxidative stress in obese Zucker rats. Of these
factors, glucose autoxidation leads to the production of
advanced glycation end products.22,25 We also observed that
obese animals have marked increase in carboxymethyllysine
levels, a marker of advanced glycation end product and
decrease in reduced glutathione was associated with sig-
nificant increase in oxidized glutathione, suggesting a failure
of the system to restore normal oxidative/antioxidative status.
Treatment of obese rats with antioxidants decreased lipid
peroxidation, protein oxidation, advanced glycation end
product, and decreased urinary excretion of 8-isoprostane.
In addition, tempol and lipoic corrected the glutathione
levels and restored the redox status, confirming the role of
these compounds as useful antioxidants. Contrary to earlier
reports, we did not find any change in expression of
NAD(P)H subunits from lean or obese rats.26 The discre-
pancy may be because most of earlier studies were performed
in vascular tissue,26 whereas in present study we used renal
proximal tubules.
At cellular level, the stimulated D1 receptors couple with
G-proteins which lead to inhibition of NKA and NHE3
via activation of various kinases such as PKC and protein
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Figure 7 | Effect of H2O2 on renal malondialehyde levels and
ERK1/2 activity. (a) Effect of H2O2 on lipid peroxidation in renal
proximal tubules from lean and obese Zucker rats. (b) Effect of H2O2
on ERK1/2 upregulation in renal proximal tubules from lean and
obese Zucker rats. Top panel represents ERK1/2 phosphorylated
protein, middle panel represents ERK1/2 protein abundance, and
lower panel (bars) represents the ratio of top and middle panel
(ERK1/2 phosphorylated protein/ ERK1/2 protein abundance). Data
were analyzed by ANOVA followed by Newman–Keuls multiple test;
Po0.05 was considered statistically significant. (a) *H2O2 significantly
different from vehicle, #vehicle-obese significantly different from
vehicle-lean. (b) *Significantly different from H2O2-lean and -obese
(vehicle or H2O2) groups.
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Figure 8 | Effect of H2O2 on renal D1 receptor expression and G-
protein coupling. Effect of H2O2 on (a) [
3H]SCH-23390 binding and
(b) SKF-38393-induced [35S]GTPgS binding in proximal tubular
membranes from lean and obese animals. Data were analyzed by
ANOVA followed by Newman–Keuls multiple test; Po0.05 was
considered statistically significant. *Significantly different from
H2O2-lean and -obese (vehicle or H2O2) groups.
Kidney International (2007) 71, 397–406 403
AA Banday et al.: Role of MAP kinase in D1 receptor dysfunction o r i g i n a l a r t i c l e
kinase A.1,5–9 Under conditions such as hypertension and
diabetes, D1 receptors are uncoupled from G-proteins and
thus fail to inhibit sodium transporters which leads to
increased sodium retention particularly during modest
increases in sodium intake.1,2,10,13 The mechanism for the
uncoupling of D1 receptors from G-proteins is currently
unknown, but abnormalities in the desensitization process of
D1 receptor might be involved.1,12,13 Previously, we have
shown that in obese Zucker rats, a model of type II diabetes
with moderate hypertension, the failure of D1 receptor to
couple with G-proteins is not caused by abnormalities in G-
proteins.13 Rather, our previous results suggested that
upregulation of G-protein-coupled receptor kinase-2 and
subsequent serine hyperphosphorylation of D1 receptors
could be responsible for its uncoupling from G-proteins. We
also showed that tempol decreased oxidative stress and
restored the D1 receptor G-protein coupling, thus implicat-
ing the role of oxidative stress.13
There are reports indicating that oxidants abolish D1
receptor high-affinity sites and reducing agents preserve and
protect such sites from oxidation.27–29 We observed that in
obese Zucker rats there is a significant increase in carbonyl
content of D1 receptors, suggesting the specific oxidative
modification of the receptor. There are two possible sites on
the receptor that can be modulated by free radicals: the
ligand binding domain and the G-protein coupling region of
the receptor.29–30 To determine the role of oxidative stress on
affinity of D1 receptors, we performed competition binding
experiments with the agonist FD, which revealed a significant
decrease in the affinity of D1 receptors in obese compared
with lean rats. Although a decrease in the agonist affinity
toward the D1 receptors may contribute to the reduced D1
receptor activation, it cannot explain the complete functional
loss of the D1 receptors. Previously, we have shown that
stimulated D1 receptors fail to couple with G-proteins in
obese animals.13 Here, we wanted to determine whether
oxidative stress affects the D1 receptor G-protein coupling
before stimulation of receptors with agonist as well. The
immunoprecipitation results showed decreased basal co-
immunoprecipitation of G-proteins with D1 receptor ligand
binding sites in obese rats compared to lean animals.
Furthermore, D1 receptor ligand SKF-38393 failed to increase
the [35S]GTPgS binding in membrane from obese animals.
These results indicate that D1 receptors are uncoupled from
cognate G-proteins at basal state and also fail to interact with
G-proteins after stimulation. Treatment of obese rats with
tempol and lipoic acid normalized the carbonyl content of
D1 receptors and restored the D1 receptor affinity and
coupling to G-proteins.
Incubation of proximal tubular membranes from obese
animals with D1 receptor agonist SKF-38393 failed to
increase cAMP accumulation suggesting a defect in D1
receptor-mediated adenylyl cyclase activation. Treatment
of obese animals with antioxidants restored the adenylyl
cyclase activation in response to SKF-38393. The failure
of SKF-38393 to activate adenylyl cyclase and increase
cAMP levels may explain the inability of D1 receptors
to inhibit sodium transporters as was observed in our
previous studies.31 It should be noted that incubation of
membranes from both lean and obese rats with forskolin
caused similar increases in cAMP levels and immunoblotting
experiments showed that the expression of G-proteins
was similar in lean and obese rats. Also, the protein
abundance and activities of NKA and NHE3 were similar
in lean and obese rats, thus indicating the defect in D1
receptor function lies in D1 receptor itself or proximal to
G-proteins/effector complex.
The observation that tempol and lipoic acid-induced
normalization of MAPK was accompanied by restoration
of the D1 receptor affinity and coupling to G-proteins
suggests the role of MAPK in oxidative stress-mediated
D1 receptor defect. Supplementation of these animals
with antioxidants normalized ERK1/2, JNK, and p38
MAPK activities and restored D1 receptor function; thus,
implicating the role MAPK in D1 receptor defect. We also
observed that incubation of proximal tubules from lean rats
with H2O2 increased ERK1/2 activity and reduced D1
receptor signaling. In addition, the incubation of proximal
tubules with MAPK kinase inhibitor before H2O2 exposure
blocked both ERK1/2 activation as well as D1 receptor
dysfunction, thus reinforcing the role of MAPK in oxidative
stress-mediated D1 receptor dysfunction.32 However,
contrary to the observations in lean animals, H2O2 failed to
upregulate ERK1/2 and reduce D1 receptor signaling in
obese animals. This could be because in obese animals ERK1/
2 is already upregulated and D1 receptors are also
desensitized before H2O2 exposure. Although the mechanism
for MAPK activation and defective D1 receptor function is
not clear, renal D1 receptor stimulation has been shown
to activate ERK1/2 and stress-activated JNK and p38
MAPK in time- and concentration-dependent manner.20 It
is possible that MAPK-mediated D1 receptor uncoupling
may be a mechanism to limit the overstimulation of D1
receptor pathways via a classical feedback mechanism.33 It
has been reported that renal D1 receptor stimulation
increases PKC activity in rats, whereas increased basal
activity of PKC in rat renal tubules leads to D1 receptor
G-protein uncoupling.34–36 Normalization of PKC activity by
antioxidant supplementation restored D1 receptor function
in these animals.14,15
In conclusion, we have shown that in obese Zucker rats
increased oxidative stress leads to D1 receptor oxidation and
ERK1/2, JNK, and p38 MAPK upregulation. This could lead
to impaired D1 receptor-mediated inhibition of sodium
transporters and natriuresis resulting in sodium retention
and subsequently hypertension in obese Zucker rats. Anti-
oxidant supplementation while reducing oxidative stress,
prevented D1 receptor oxidation and normalized ERK1/2,
JNK, and p38 MAPK activation in obese animals. These
phenomena could account for restoration of D1 receptor
signaling and ability of dopamine to inhibit sodium
transporters and promote sodium excretion.
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MATERIALS AND METHODS
Antibodies for G-proteins, MAPK (including c-jun), NAD(P)H, and
D1 receptors were obtained from Calbiochem-Novabiochem, Cell
Signaling, Transduction Laboratory, and Alpha Diagnostic Intl,
respectively. Glutathione colorimetric determination kit, Protein
Oxidation Detection Kit, 8-Isoprostane EIA Kit, and protease
inhibitor cocktail tablets were purchased from OXIS International
Inc. (Foster city, CA, USA), Chemicon International (Temecula, CA,
USA), Cayman Chemical (Ann Arbor, MI, USA), and Roche
Diagnostic (Indianapolis, IN, USA), respectively. [3H]SCH-23390
and [35S]GTPgS were purchased from NEN Life Sciences. SKF-
38393 and all other chemicals of highest purity were purchased from
Sigma-Aldrich (St. Louis, MO, USA).
Animals
Male 7- to 9-week-old lean and obese Zucker rats were purchased from
Harlan (Indianapolis, IN, USA) and maintained at an ambient
temperature. For treatment purposes, both lean and obese animals
were divided into two groups; control groups, where animals were
continued on tap water or normal diet and treated groups were animals
provided with tempol in tap water or diet supplemented with 0.4%
lipoic acid for 2 weeks. Food and water were changed twice a day.
Preparation of renal proximal tubular suspension
Renal proximal tubular suspension was prepared as described
earlier.11,13,14 Briefly, rats were anesthetized with sodium pentobar-
bital (50 mg/kg, intraperitoneally) and after a midline incision, the
aorta was cannulated below the kidneys and an in situ digestion was
accomplished by perfusing an enzyme solution of collagenase and
hyaluronidase. Enrichment of proximal tubules was carried out
using 20% ficoll gradient in Krebs buffer.
[35S]GTPcS binding to G-proteins
Membrane [35S]GTPgS binding to G-proteins was performed
according to Friedman et al.37 Briefly, the assay mixture (250 ml)
containing 200 mg of membrane protein and 2 nm [35S]GTPgS was
incubated for 5 min at 251C, followed by incubation in the absence
or presence of D1 receptor agonist (SKF-38393) for 5 min. The
reaction was terminated and G-proteins were immunoprecipitated
with Gas or Gai antiserum.
Co-immunoprecipitation of [3H]SCH-23390 bound receptor
with discrete Ga proteins
Solubilized membranes were combined with antisera (1:1000
dilution) raised against specific peptides of Ga or Gai proteins for
3 h at 41C followed by an additional 30-min incubation with 100 ml
of Pansorbin cells.38 The mixture was centrifuged and washed, and
the pellet was suspended and incubated for 30 min at 301C in 500 ml
of 50 mM Tris-HCl binding buffer, pH 7.5, which included 5 mM
MgCl2 and 1 nM [
3H]SCH-23390. The reaction was terminated by
the addition of 9 ml of ice-cold buffer, vacuum filtered, and
radioactivity was determined by liquid scintillation counting.
Immunoblotting and MAPK activity
Proteins were solubilized in Laemmli buffer, separated by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis, and transferred
to nitrocellulose membrane. The membranes were blocked,
incubated with antisera directed against G-proteins (Ga, Gai),
MAPK, and NAD(P)H oxidase in 0.1% Tris-buffered saline followed
by incubation with horseradish peroxidase-conjugated secondary
antibodies. For ERK1/2 or p38 activation, the blots were incubated
for 12 h with antiphosphospecific ERK1/2 and p38 or antibodies
that recognize ERK1/2 and p38. JNK activity was measured with a
commercially available kit based on phosphorylation of recombi-
nant c-jun.
Adenylyl cyclase assay
The adenylyl cyclase assay was performed as described by Salomon
et al.39 The reaction was started by the addition of 50 mg of
membrane protein to 1 mCi of [a-32P]ATP (B2.2 106 c.p.m.) with
or without SKF-38393. The reaction was terminated by 2% sodium
dodecyl sulfate buffer and [32P]cAMP was separated by Dowex and
alumina columns.
Competition radioligand binding assay
FD, a D1 receptor agonist, was used to displace membrane bound
radioligand [3H]SCH-23390. The reaction mixture contained 4 nM
radioligand, 50 mg membrane proteins, and variable concentration
(1010–103 M) of FD in a 250-ml assay buffer (final volume)
containing (in mM) 50 Tris-HCl, 2 MgCl2, 0.2 sodium metabisulfite,
and 0.2 phenylmethylsulfonyl fluoride, pH 7.4. The reaction was
carried out for 120 min at 251C, terminated by filtration, and
counted for radioactivity.
NKA and NHE3 assay
Proximal tubular NKA activity was determined by the method of
Szczepanska-Konkel et al.40 This method uses plasma membrane
preparations containing mainly BLM as determined by marked
enrichment of NKA activity, nmol Pi/mg protein/min (lean-homo-
genate – 25.471.8, lean-BLM – 260.2718.6; obese-homogenate –
28.471.7, obese-BLM – 292.2720.6). NHE3 activity was assayed by
measuring 5-(N-methyl-N-isobutyl)-amiloride-sensitive 22Naþ uptake
as described in detail by Albrecht et al.41 The enrichment of BBM was
confirmed by increased activity of typical BBM enzymes g-glutamyl-
transferase (data not shown) and alkaline phosphatase, nmol Pi/mg
protein/min (lean-homogenate – 14.471.2, lean-BBM – 148.275.6;
obese-homogenate – 15.471.6, obese-BBM – 162.379.7) and decrease
in basolateral enzyme activity (data not shown).
Indexes (biomarkers) of oxidative stress
A biooxytech GSH/GSSG-412 kit was used to measure reduced and
oxidized glutathione in renal proximal tubules, D1R-DNPH was
measured by OxyBlot Protein Oxidation Detection Kit, and 8-ISO
PGF2a was measured by radioimmunoassay kit. Carboxymethylly-
sine was measured by enzyme-linked immunosorbent assay as
described by Koo and Vaziri.42 Endothelial NOS monomer/dimer
ratio was measured by low-temperature sodium dodecyl sulfate-
polyacrylamide gel electrophoresis low temperature polyacrylamide
gel electrophoresis (LT-PAGE).43 Fluorescence spectrometric assay of
O2
 production was performed as described by Satoh et al.44
Statistical analysis
Difference between means were evaluated using the unpaired t-test
or analysis of variance (ANOVA) with Newman–Keuls’ multiple test,
as appropriate, Po0.05 was considered statistically significant.
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